<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bochicchio D</submitter><funding>GlaxoSmithKline</funding><funding>Alzheimer Research UK</funding><funding>FP7 Health</funding><pagination>596-605</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10172255</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(3)</volume><pubmed_abstract>Long-term memory requires stable protein synthesis and is altered in Alzheimer's disease (AD). This study aimed to implement a method to measure the cerebral protein synthesis rate (PSR) with [11C]leucine PET in vivo in rats and evaluate potential PSR alterations longitudinally (6, 12 and 18 months old) in the TgF344-AD rat model of AD. Wistar, wild-type (WT) and TgF344-AD rats (TG) were scanned for 60 min with [11C]leucine. Arterial blood activity was monitored online and with discrete whole blood and plasma samples by γ-counting in Wistar rats, WT (n = 4) and TG (n = 5). Unlabelled amino acids were measured in plasma. The sensitivity of [11C]leucine PET to measure alterations in PSR was assessed in Wistar rats by injection of PSR inhibitor anisomycin before PET acquisition. Anisomycin ad</pubmed_abstract><journal>Molecular imaging and biology</journal><pubmed_title>Measurement of Protein Synthesis Rate in Rat by [11C]Leucine PET Imaging: Application to the TgF344-AD Model of Alzheimer's Disease.</pubmed_title><pmcid>PMC10172255</pmcid><funding_grant_id>HEALTH-F2-2011-278850</funding_grant_id><pubmed_authors>Parker CA</pubmed_authors><pubmed_authors>Bochicchio D</pubmed_authors><pubmed_authors>Boutin H</pubmed_authors><pubmed_authors>Herholz K</pubmed_authors><pubmed_authors>Hinz R</pubmed_authors><pubmed_authors>Christie L</pubmed_authors><pubmed_authors>Lawrence CB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Measurement of Protein Synthesis Rate in Rat by [11C]Leucine PET Imaging: Application to the TgF344-AD Model of Alzheimer's Disease.</name><description>Long-term memory requires stable protein synthesis and is altered in Alzheimer's disease (AD). This study aimed to implement a method to measure the cerebral protein synthesis rate (PSR) with [11C]leucine PET in vivo in rats and evaluate potential PSR alterations longitudinally (6, 12 and 18 months old) in the TgF344-AD rat model of AD. Wistar, wild-type (WT) and TgF344-AD rats (TG) were scanned for 60 min with [11C]leucine. Arterial blood activity was monitored online and with discrete whole blood and plasma samples by γ-counting in Wistar rats, WT (n = 4) and TG (n = 5). Unlabelled amino acids were measured in plasma. The sensitivity of [11C]leucine PET to measure alterations in PSR was assessed in Wistar rats by injection of PSR inhibitor anisomycin before PET acquisition. Anisomycin ad</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2025-04-22T08:51:33.113Z</modification><creation>2025-04-05T22:43:22.905Z</creation></dates><accession>S-EPMC10172255</accession><cross_references><pubmed>36538180</pubmed><doi>10.1007/s11307-022-01796-0</doi></cross_references></HashMap>